CELISA MCGRONE: Open Payments
NPI 1770035248 · SANDY SPRINGS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$650 in 31 payments from 9 companies in 2025. Trend: 2023 $1,024 · 2024 $1,023 · 2025 $650
Food & beverage: $551Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $157 |
| Astellas Pharma US Inc | 4 | $154 |
| Lilly USA, LLC | 6 | $99 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $62 |
| ABBVIE INC. | 2 | $40 |
| Amgen Inc. | 2 | $33 |
| Esperion Therapeutics, Inc. | 1 | $25 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
Products named: Ozempic, Rybelsus, MOUNJARO, Kerendia, Veozah, AIRSUPRA, EVENITY, NEXLETOL.
Industry payments across GA — which companies pay providers there.
